<DOC>
	<DOC>NCT02684344</DOC>
	<brief_summary>This randomized open-label study will be comprised of 2 cohorts: one control group and one treatment group. The trial will be conducted as an open label randomized trial to evaluate the efficacy of tamsulosin in the prevention of post-operative urinary retention. The study will include pre- and post-surgical evaluations of patients including symptoms of urinary retention and any adverse effects contributable to the study medication.</brief_summary>
	<brief_title>Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention</brief_title>
	<detailed_description />
	<mesh_term>Urinary Retention</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Any male age 40 or older Scheduled to undergo one of the planned surgeries (thoracic, general, or urologic) Ability to give informed consent Current use of alpha blocker Current use of a strong CYP 3A4 inhibitors Any allergy to tamsulosin, alphablocker medication class, or anaphylaxis allergy to sulfate containing medications Patients with any upcoming surgery for cataracts Currently enrolled in a clinical trial Inability to give informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Post-Operative Urinary Retention</keyword>
</DOC>